Clinical trial
Open-label, Pilot Protocol of Patients With Rheumatoid Arthritis Who Switch to…
NCT00317538 · Centocor Ortho Biotech Services, L.L.C., Industry · Completed
Key facts
| NCT number | NCT00317538 |
|---|---|
| Title | Open-label, Pilot Protocol of Patients With Rheumatoid Arthritis Who Switch to Infliximab After Incomplete Response to Etanercept |
| Official title | Open-label, Pilot Protocol of Patients With Rheumatoid Arthritis Who Switch to Infliximab After Incomplete Response to Etanercept |
| Lead sponsor | Centocor Ortho Biotech Services, L.L.C., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | infliximab, etanercept |
| Enrollment | 28 |
| Start date | Jun 1, 2003 |
| Completion | Nov 1, 2004 |
| First posted | Apr 25, 2006 |
| Last update posted | May 19, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: